Clinical Trials Browser

Prostatic Neoplasms

NCT05005728 2026-05-05

XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2 Completed

72 enrolled

Genitourinary

Prostatic Neoplasms

NCT02115165 2026-04-06

CABA-GCT

Phase 2 Completed

34 enrolled

Nonseminomatous germ cell tumor

NCT01616875 2026-03-06

Bristol Bladder Trial

Phase 2 Completed

28 enrolled 21 charts

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03556904 2026-01-15

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

Phase 2 Completed

14 enrolled 16 charts

Genitourinary

Prostatic Neoplasms

NCT02985957 2025-12-22

CheckMate 650

Phase 2 Completed

351 enrolled 43 charts

Genitourinary

Prostatic Neoplasms

NCT01437488 2025-05-04

Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy

Phase 2 Completed

14 enrolled 12 charts

Genitourinary

Carcinoma, Transitional Cell

NCT02218606 2024-12-10

Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer

Phase 2 Completed

81 enrolled 11 charts

Genitourinary

Prostatic Neoplasms

NCT02903160 2024-02-07

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

Phase 2 Completed

40 enrolled 18 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02543255 2024-01-31

ACDC-RP

Phase 2 Completed

76 enrolled

Genitourinary

Prostatic Neoplasms

NCT04495179 2023-08-09

AARDVARC

Phase 2 Completed

30 enrolled 22 charts

Genitourinary

Prostatic Neoplasms

NCT03114254 2022-11-18

JAVA-P

Phase 2 Completed

17 enrolled

Genitourinary

Neoplasm Metastasis, Penile Neoplasms, Recurrence

NCT03392428 2022-06-13

TheraP

Phase 2 Completed

201 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT03101046 2022-02-10

TACTIK

Phase 2 Completed

40 enrolled

Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT01913652 2021-09-14

Ph II Cabazitaxel DD Liposarcoma

Phase 2 Completed

42 enrolled

Sarcoma

Liposarcoma

NCT01620242 2021-03-02

ORL03

Phase 2 Completed

31 enrolled

Head & Neck

Head and Neck Neoplasms, Recurrence

NCT02560337 2020-10-08

CaTo-ROC

Phase 2 Completed

26 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT02512458 2020-02-10

CABA-BONE

Phase 2 Completed

60 enrolled

Genitourinary

Bone Metastatic Prostate Cancer

NCT01956149 2018-04-18

Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer

Phase 2 Completed

65 enrolled

Gastrointestinal

Stomach Neoplasms

NCT01757171 2018-04-03

Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma

Phase 2 Completed

85 enrolled 11 charts

Gastrointestinal

Stomach Neoplasms

NCT01718353 2017-11-20

TAXYNERGY

Phase 2 Completed

63 enrolled 13 charts

Genitourinary

Prostate Cancer Metastatic

NCT01866449 2017-10-26

Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme

Phase 2 Completed

24 enrolled

CNS

Glioblastoma

NCT01693549 2017-08-01

Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes

Phase 2 Completed

84 enrolled

Breast

Breast Neoplasms

NCT01518283 2017-07-02

Study of Weekly Cabazitaxel for Advanced Prostate Cancer

Phase 2 Completed

74 enrolled

Genitourinary

Hormone Refractory Prostate Cancer

NCT01528163 2017-06-14

RACATREX

Phase 2 Completed

101 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT01438307 2017-05-24

Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

28 enrolled 11 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01541007 2015-11-02

ConCab

Phase 2 Completed

100 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT01852578 2015-09-28

Cabazitaxel in Relapsed and Metastatic NSCLC

Phase 2 Completed

46 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01600339 2015-05-12

A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)

Phase 2 Completed

19 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT01500720 2015-04-13

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Phase 2 Completed

179 enrolled 16 charts

Thoracic

Small Cell Lung Carcinoma

NCT01576029 2013-12-24

SWITCH

Phase 2 Completed

2 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

CABA-GCT

Bristol Bladder Trial

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

CheckMate 650

Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy

Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

ACDC-RP

AARDVARC

JAVA-P

TheraP

TACTIK

Ph II Cabazitaxel DD Liposarcoma

ORL03

CaTo-ROC

CABA-BONE

Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer

Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma

TAXYNERGY

Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme

Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes

Study of Weekly Cabazitaxel for Advanced Prostate Cancer

RACATREX

Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer

ConCab

Cabazitaxel in Relapsed and Metastatic NSCLC

A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

SWITCH